We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva, Lonza Drugmakers Sign Biosimilars Agreement
Teva, Lonza Drugmakers Sign Biosimilars Agreement
February 3, 2009
Teva Pharmaceutical Industries and Lonza Group are establishing a joint venture to develop, manufacture and market biosimilars.